Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease

NCT07496021 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Early Alzheimers Disease

Interventions

DRUG: L. lactis CKDB001
DRUG: Placebo

Sponsor

CKD Bio Corporation